Edap Tms S.A. (NASDAQ:EDAP) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 421,560 shares, a growth of 154.6% from the May 15th total of 165,551 shares. Based on an average daily volume of 87,378 shares, the days-to-cover ratio is currently 4.8 days.

A number of equities analysts have weighed in on EDAP shares. HC Wainwright reiterated a “buy” rating and set a $7.00 target price on shares of Edap Tms in a research report on Friday, April 7th. ValuEngine upgraded shares of Edap Tms from a “sell” rating to a “hold” rating in a research report on Friday, May 19th. Finally, Zacks Investment Research upgraded shares of Edap Tms from a “strong sell” rating to a “hold” rating in a research report on Thursday, May 18th.

Edap Tms (NASDAQ:EDAP) last released its earnings results on Wednesday, May 17th. The medical equipment provider reported $0.13 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.16. The company had revenue of $9.29 million during the quarter, compared to analyst estimates of $9.35 million. Edap Tms had a net margin of 11.95% and a return on equity of 27.90%.

A hedge fund recently raised its stake in Edap Tms stock. Perkins Capital Management Inc. raised its stake in Edap Tms S.A. (NASDAQ:EDAP) by 184.3% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 276,500 shares of the medical equipment provider’s stock after buying an additional 179,250 shares during the period. Perkins Capital Management Inc. owned approximately 0.95% of Edap Tms worth $766,000 at the end of the most recent quarter. 8.05% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Edap Tms S.A. (EDAP) Short Interest Update” was reported by American Banking News and is owned by of American Banking News. If you are reading this article on another domain, it was stolen and reposted in violation of United States and international trademark & copyright laws. The correct version of this article can be read at https://www.americanbankingnews.com/2017/06/13/edap-tms-s-a-edap-short-interest-update.html.

About Edap Tms

EDAP TMS SA (EDAP) is a holding company engaged in developing and marketing the Ablatherm and Focal One devices. The Company operates two divisions: High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) (including lithotripsy activities). The Company is developing HIFU technology for the treatment of certain other types of tumors.

Receive News & Ratings for Edap Tms S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms S.A. and related companies with MarketBeat.com's FREE daily email newsletter.